Soligenix, Inc. (NASDAQ:SNGX) has a beta value of 1.31 and has seen 1,996,050 shares traded in the recent trading session. The company, currently valued at $59.27 Million, closed the recent trade at $2.23 per share which meant it gained $0.1 on the day or 6.7% during that session. The SNGX stock price is -58.74% off its 52-week high price of $3.54 and 68.16% above the 52-week low of $0.71. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.26 Million shares traded. The 3-month trading volume is 1.12 Million shares.

The consensus among analysts is that Soligenix, Inc. (SNGX) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 3 have rated it as a Hold, with 3 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.13.

Soligenix, Inc. (NASDAQ:SNGX) trade information

Sporting 5.74% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Jun 29 when the SNGX stock price touched $2.47-8 or saw a rise of 8.5%. Year-to-date, Soligenix, Inc. shares have moved 55.86%, while the 5-day performance has seen it change 20.21%. Over the past 30 days, the shares of Soligenix, Inc. (NASDAQ:SNGX) have changed 18.32%. Short interest in the company has seen 369.46 Million shares shorted with days to cover at 329.88.

Wall Street analysts have a consensus price target for the stock at $4.75, which means that the shares’ value could jump 113% from current levels. The projected low price target is $3 while the price target rests at a high of $7.25. In that case, then, we find that the current price level is +225.11% off the targeted high while a plunge would see the stock lose 34.53% from current levels.

Soligenix, Inc. (SNGX) estimates and forecasts

Figures show that Soligenix, Inc. shares have underperformed across the wider relevant industry. The company’s shares have gained +44.14% over the past 6 months, with this year growth rate of 2.08%, compared to 9.2% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are -8.3% and 14.3% for the next quarter. Revenue growth from the last financial year stood is estimated to be -40%.

3 analysts offering their estimates for the company have set an average revenue estimate of $700Million for the current quarter. 3 have an estimated revenue figure of $700Million for the next quarter concluding in September 01, 2020. Year-ago sales stood $1.54 Million and $1.25 Million respectively for this quarter and the next, and analysts expect sales will grow by -54.7% for the current quarter and -44.2% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +31.7% over the past 5 years. Earnings growth for 2020 is a modest +28.5% while over the next 5 years, the company’s earnings are expected to increase by 1%.